Prelude Capital Management’s Medpace MEDP Stock Holding History

Prelude Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,000	Closed	-$654K	–	1958
2022 Q1	$654K	Buy	+4,000	New	+$660K	0.02%	735

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Prelude Capital Management's MEDP Position: Q1 2026 in Review

Prelude Capital Management sold out of Medpace (MEDP) in Q1 2026, closing a stake of 430 shares — an estimated $242K sold.

Prelude Capital Management first reported a position in MEDP in Q1 2017 and held it in 24 quarters. The position peaked at $2.49M in Q2 2023. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Prelude Capital Management reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
Prelude Capital Management sold 430 Medpace shares in Q1 2026, an estimated $242K.
Prelude Capital Management first reported a position in Medpace in Q1 2017 and held it in 24 quarters.
Prelude Capital Management's Medpace position peaked at $2.49M in Q2 2023.
729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.